These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 11364452

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. New protease inhibitor available through expanded access.
    Posit Aware; 1996; 7(6):7. PubMed ID: 11363981
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Saquinavir gets accelerated approval.
    McGuire S.
    Posit Aware; 1996 Jan; 7(1):8. PubMed ID: 11363135
    [Abstract] [Full Text] [Related]

  • 30. Saquinavir (Invirase).
    Treat Rev; 1996 Apr; (no 21):5. PubMed ID: 11363396
    [Abstract] [Full Text] [Related]

  • 31. Quadruple-2 protease inhibitors (PI)-therapy does not accelerate viral decay and suppression in PI-naive HIV-1 infected patients with severe immunosuppression and high viral load as compared with standard triple therapy.
    Portilla J, Boix V, Garcia-Henarejos JA, Llopis C, Martínez-Madrid O, Gimeno A, Sánchez-Paya J, Merino E.
    Int J STD AIDS; 2005 Dec; 16(12):807-10. PubMed ID: 16336763
    [Abstract] [Full Text] [Related]

  • 32. Stanford study of saquinavir reveals low toxicities.
    AIDS Patient Care; 1995 Dec; 9(6):304-5. PubMed ID: 11361442
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Soft gel saquinavir has high exposure.
    AIDS Alert; 1997 Dec; 12(12):143-4. PubMed ID: 11364835
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. HIV-1 protease inhibitors.
    Deeks SG, Volberding PA.
    AIDS Clin Rev; 1997 Dec; ():145-85. PubMed ID: 9305448
    [No Abstract] [Full Text] [Related]

  • 39. FDA rapidly approves HIV protease inhibitors for children.
    Fox JL.
    Nat Biotechnol; 1997 May; 15(5):404. PubMed ID: 9131607
    [No Abstract] [Full Text] [Related]

  • 40. The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy.
    Staszewski S, Babacan E, Stephan C, Haberl A, Carlebach A, Gute P, Klauke S, Hermschulte Y, Stuermer M, Dauer B, Frankfurt HIV Cohort.
    J Antimicrob Chemother; 2006 Nov; 58(5):1024-30. PubMed ID: 16956902
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.